ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Clinical trial NCT04561518 updates: 1. completion date: 2030-09-01 → 2033-12-31 2. primary completion date: 2030-09-01 → 2033-12-31 3. enrollment: not set → 1500 participants
Clinical trial NCT04561518 updates: 1. completion date: 2030-09-01 → 2033-12-31 2. primary completion date: 2030-09-01 → 2033-12-31 3. enrollment: not set → 1500 participants
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical